Overview

Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock

Status:
Unknown status
Trial end date:
2020-10-31
Target enrollment:
Participant gender:
Summary
Due to the high incidence, mortality and short and long term complications of sepsis and septic shock, it is necessary to look for strategies to try to minimize this impact.
Phase:
Phase 3
Details
Lead Sponsor:
Cristina Martinez
Treatments:
Ascorbic Acid
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Thiamine
Tranexamic Acid
Vitamins